The Latest in Conference Coverage

VIDEO: Biosimilars show promise and progress

November 11, 2016

Psoriasis

Optimize anti–TNF-alpha therapy for psoriasis

November 11, 2016

Psoriasis

VIDEO: IL-23 inhibitors on the upswing

November 11, 2016

Psoriasis

Include quality of life measures in evaluating treatment success of psoriasis

November 11, 2016

Psoriasis

Biologic-naive psoriasis patients get biggest boost with treatment

November 11, 2016

Psoriasis

Study offers reassuring data on certolizumab use in pregnancy

November 10, 2016

Psoriasis

What good are biosimilars if patients won’t use them?

November 5, 2016

Psoriasis

Close monitoring of psoriasis patients can delay PsA onset

November 2, 2016

Psoriasis

Tildrakizumab for psoriasis scores high marks in phase III

October 19, 2016

Psoriasis

Secukinumab for psoriasis at 4 years: undiminished efficacy and safety

October 18, 2016

Psoriasis

Guselkumab achieves highest-ever response rates in psoriasis

October 12, 2016

Psoriasis

Birth outcomes unaffected by paternal immunosuppressive therapy

October 12, 2016

Psoriasis

Shining a light on nonplaque psoriasis

July 28, 2016

Psoriasis

Skin microbiome may differ in unique ways in psoriatic arthritis, psoriasis patients

July 25, 2016

Psoriasis

Ultrasound’s role in detecting enthesitis in psoriatic arthritis remains debatable

July 25, 2016

Psoriasis